Statin pretreatment and risk of in-hospital atrial fibrillation among patients undergoing cardiac surgery: a collaborative meta-analysis of 11 randomized controlled trials


Creative Commons License

Patti G., Bennett R., Seshasai S. R. K., Cannon C. P., Cavallari I., Chello M., ...Daha Fazla

EUROPACE, cilt.17, sa.6, ss.855-863, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 17 Sayı: 6
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1093/europace/euv001
  • Dergi Adı: EUROPACE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.855-863
  • Anahtar Kelimeler: Statins, Cardiac surgery, Postoperative atrial fibrillation, Meta-analysis, ENDOTHELIAL PROGENITOR CELLS, PREOPERATIVE STATINS, UPSTREAM THERAPIES, CLINICAL-EVIDENCE, CORONARY SURGERY, EUROPEAN-SOCIETY, BYPASS-SURGERY, DOUBLE-BLIND, TROPONIN-I, ATORVASTATIN
  • Ankara Üniversitesi Adresli: Evet

Özet

Aims Statin pretreatment in patients undergoing cardiac surgery is understood to prevent postoperative atrial fibrillation (AF). However, this is based on observational and limited randomized trial evidence, resulting in uncertainty about any genuine anti-arrhythmic benefits of these agents in this setting. We therefore aimed to quantify precisely the association between statin pretreatment and postoperative AF among patients undergoing cardiac surgery.